High-flow nasal cannula oxygen therapy in adults

Masaji Nishimura, Masaji Nishimura

Abstract

High-flow nasal cannula (HFNC) oxygen therapy comprises an air/oxygen blender, an active humidifier, a single heated circuit, and a nasal cannula. It delivers adequately heated and humidified medical gas at up to 60 L/min of flow and is considered to have a number of physiological effects: reduction of anatomical dead space, PEEP effect, constant fraction of inspired oxygen, and good humidification. While there have been no big randomized clinical trials, it has been gaining attention as an innovative respiratory support for critically ill patients. Most of the available data has been published in the neonatal field. Evidence with critically ill adults are poor; however, physicians apply it to a variety of patients with diverse underlying diseases: hypoxemic respiratory failure, acute exacerbation of chronic obstructive pulmonary disease, post-extubation, pre-intubation oxygenation, sleep apnea, acute heart failure, patients with do-not-intubate order, and so on. Many published reports suggest that HFNC decreases breathing frequency and work of breathing and reduces needs of escalation of respiratory support in patients with diverse underlying diseases. Some important issues remain to be resolved, such as its indication, timing of starting and stopping HFNC, and escalating treatment. Despite these issues, HFNC oxygen therapy is an innovative and effective modality for the early treatment of adults with respiratory failure with diverse underlying diseases.

Keywords: Anatomical dead space; Clinical trials; Oxygen therapy; PEEP effect; Physiological effects.

Figures

Figure 1
Figure 1
Principle setup of high-flow nasal cannula oxygen therapy. An air/oxygen blender, allowing from 0.21 to 1.0 FIO2, generates up to 60 L/min flow. The gas is heated and humidified through an active heated humidifier and delivered via a single-limb heated inspiratory circuit. The patient breathes the adequately heated and humidified medical gas through nasal cannulas with a large diameter.

References

    1. Girou E, Brun-Buisson C, Taillé S, Lemaire F, Brochard L. Secular trends in nosocomial infections and mortality associated with noninvasive ventilation in patients with exacerbation of COPD and pulmonary edema. JAMA. 2003;290(22):2985–91. doi: 10.1001/jama.290.22.2985.
    1. Campbell EJ, Baker MD, Crites-Silver P. Subjective effects of humidification of oxygen for delivery by nasal cannula. A prospective study. Chest. 1988;93:289–93. doi: 10.1378/chest.93.2.289.
    1. Chanques G, Contantin JM, Sauter M, Jung B, Sebbane M, Verzilli D. Discomfort associated with underhumidified high-flow oxygen therapy in critically ill patients. Intensive Care Med. 2009;35(6):996–1003. doi: 10.1007/s00134-009-1456-x.
    1. Mayfield S, Jauncey-Cook J, Hough JL, Schibler A, Gibbons K, Bogossian F. High-flow nasal cannula therapy for respiratory support in children. Cochrane Database Syst Rev. 2014;3:CD009850.
    1. Dani C, Pratesi S, Migliori C, Bertini G. High flow nasal cannula therapy as respiratory support in the preterm infant. Pediatr Pulmonol. 2009;44(7):629–34. doi: 10.1002/ppul.21051.
    1. Itagaki T, Okuda N, Tsunano Y, Kohata H, Nakataki E, Onodera M, et al. Effect of high-flow nasal cannula on thoraco-abdominal synchrony in adult critically ill patients. Respir Care. 2014;59:70–4. doi: 10.4187/respcare.02480.
    1. Sztrymf B, Messika J, Bertrand F, Hurel D, Leon R, Dreyfuss D, et al. Beneficial effects of humidified high flow nasal oxygen in critical care patients: a prospective pilot study. Intensive Care Med. 2011;37:1780–6. doi: 10.1007/s00134-011-2354-6.
    1. Sztrymf B, Messika J, Mayot T, Lenglet H, Dreyfuss D, Ricard J-D. Impact of high-flow nasal cannula oxygen therapy on intensive care unit patients with acute respiratory failure: a prospective observational study. J Crit Care. 2012;27:324.e9–13. doi: 10.1016/j.jcrc.2011.07.075.
    1. Roca O, Riera J, Torres F, Masclans JR. High-flow oxygen therapy in acute respiratory failure. Respir Care. 2010;55:408–13.
    1. Corley A, Caruana LR, Barnett AG, Tronstad O, Fraser JF. Oxygen delivery through high-flow nasal cannulae increase end-expiratory lung volume and reduce respiratory rate in post-cardiac surgical patients. Br J Anaesth. 2011;107(6):998–1004. doi: 10.1093/bja/aer265.
    1. Frizzola M, Miller TL, Rodriguez ME, Zhu Y, Rojas J, Hesek A, et al. High-flow nasal cannula: impact on oxygenation and ventilation in an acute lung model. Pediatr Pulmonol. 2011;46:67–74. doi: 10.1002/ppul.21326.
    1. Wettstein RB, Shelledy DC, Peters JI. Delivered oxygen concentrations using low-flow and high-flow nasal cannulas. Respir Care. 2005;50(5):604–9.
    1. Lampland AL, Plumm B, Meyers PA, Worwa CT, Mammel MC. Observational study of humidified high-flow nasal cannula compared with nasal continuous positive airway pressure. J Pediatr. 2009;154(2):177–82. doi: 10.1016/j.jpeds.2008.07.021.
    1. Parke R, McGunness S, Eccleston M. Nasal high-flow therapy delivers low level positive airway pressure. Br J Anaesth. 2009;103:886–90. doi: 10.1093/bja/aep280.
    1. Ritchie JE, Williams AB, Gerard C, Hockey H. Evaluation of a humidified nasal high-flow oxygen system, using oxygraphy, capnography and measurement of upper airway pressures. Anaesth Intensive Care. 2011;39:1103–10.
    1. Groves N, Tobin A. High flow nasal oxygen generates positive airway pressure in adult volunteers. Aust Crit Care. 2007;20:126–31. doi: 10.1016/j.aucc.2007.08.001.
    1. Parke RL, McGuinness SP. Pressures delivered by nasal high flow oxygen during all phases of the respiratory cycle. Respir Care. 2013;58(10):1621–4. doi: 10.4187/respcare.02358.
    1. Riera J, Pérez P, Cortés J, Roca O, Masclans JR, Rello J. Effect of high-flow nasal cannula and body position on end-expiratory lung volume: a cohort study using electrical impedance tomography. Respir Care. 2013;58:589–96. doi: 10.4187/respcare.02086.
    1. Bazuaye EA, Stone TN, Corris PA, Gibson GJ. Variability of inspired oxygen concentration with nasal cannulas. Thorax. 1992;47:609–11. doi: 10.1136/thx.47.8.609.
    1. Markovitz GH, Colthurst J, Storer TW, Cooper CB. Effective inspired oxygen concentration measured via transtracheal and oral gas analysis. Respir Care. 2010;55:453–9.
    1. Andres D, Thurston N, Brant R, Flemons W, Fofonoff D, Ruttimann A, et al. Randomized double-blind trial of the effects of humidified compared with nonhumidified low flow oxygen therapy on the symptoms of patients. Can Respir J. 1997;4:76–80.
    1. Campbell EJ, Baker MD, Crites-Silver P. Subjective effects of humidification of oxygen for delivery by nasal cannula. A prospective study. Chest. 1988;93(2):289–93. doi: 10.1378/chest.93.2.289.
    1. Berk JL, Lenner KA, McFadden ER., Jr Cold-induced bronchoconstriction: role of cutaneous reflexes vs direct airway effects. J Appl Physiol. 1987;63(2):659–64.
    1. Fontanari P, Burnet H, Zattara-Hartmann MC, Jammes Y. Changes in airway resistance induced by nasal inhalation of cold dry, dry, or moist air in normal individuals. J Appl Physiol. 1996;81:1739–43.
    1. Greenspan JS, Wolfson MR, Shaffer TH. Airway responsiveness to low inspired gas temperature in preterm neonates. J Pediatr. 1991;118(3):443–5. doi: 10.1016/S0022-3476(05)82165-1.
    1. Saslow JG, Aghai ZH, Nakhla TA, Hart JJ, Lawrysh R, Stahl GE, et al. Work of breathing using high-flow nasal cannula in preterm infants. J Perinatol. 2006;26(8):476–80. doi: 10.1038/sj.jp.7211530.
    1. Salah B, Dinh Xuan AT, Fouilladieu JL, Lockhart A, Regnard J. Nasal mucociliary transport in healthy subjects is slower when breathing dry air. Eur Respir J. 1988;1(9):852–5.
    1. Oto J, Nakataki E, Okuda N, Onodera M, Imanaka H, Nishimura M. Hygrometric properties of inspired gas and oral dryness in patients with acute respiratory failure during noninvasive ventilation. Respir Care. 2014;59(1):39–45. doi: 10.4187/respcare.02351.
    1. Oto J, Imanaka H, Nishimura M. Clinical factors affecting inspired gas humidification and oral dryness during noninvasive ventilation. J Crit Care. 2011;26(5):535.e9–15. doi: 10.1016/j.jcrc.2010.10.005.
    1. Chikata Y, Izawa M, Okuda N, Itagaki T, Nakataki E, Onodera M, et al. Humidification performances of two high flow nasal cannula devices: a bench study. Respir Care. 2014;59(8):1186–90. doi: 10.4187/respcare.02932.
    1. Dewan NA, Bell CW. Effect of low flow and high flow oxygen delivery on exercise tolerance and sensation of dyspnea. A study comparing the transtracheal catheter and a nasal prongs. Chest. 1994;105(4):1061–5. doi: 10.1378/chest.105.4.1061.
    1. Brochard L, Mancebo J, Wysocki M, Lofaso F, Conti G, Rauss A, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 1995;333(13):817–22. doi: 10.1056/NEJM199509283331301.
    1. Ozyilmaz E, Ozsancak A, Nava S. Timing of noninvasive ventilation failure: causes, risk factors, and potential remedies. BMC Pulm Med. 2014;14:19. doi: 10.1186/1471-2466-14-19.
    1. Nicolini A, Ferrera L, Santo M, Ferrari-Bravo M, Del Forno M, Sclifò F. Noninvasive ventilation for hypercapnic exacerbation of chronic obstructive pulmonary disease: factors related to noninvasive ventilation failure. Pol Arch Med Wewn. 2014;124(10):525–31.
    1. Millar J, Lutton S, O’Connor P. The use of high-flow nasal oxygen therapy in the management of hypercarbic respiratory failure. Ther Adv Respir Dis. 2014;8(2):63–4. doi: 10.1177/1753465814521890.
    1. Bräunlich J, Beyer D, Mai D, Hammerschmidt S, Seyfarth H-J, Wirtz H. Effects of nasal high flow on ventilation in volunteers, COPD and idiopathic pulmonary fibrosis patients. Respiration. 2013;85:319–25. doi: 10.1159/000342027.
    1. Nilius G, Franke K-J, Domanski U, Rühle K-H, Kirkness JP, Schneider H. Effects of nasal insufflation on arterial gas exchange and breathing pattern in patients with chronic obstructive pulmonary disease and hypercapnic respiratory failure. Adv Exp Med Biol. 2013;755:27–34. doi: 10.1007/978-94-007-4546-9_4.
    1. Chatila W, Nugent T, Vance G, Gaughan J, Criner GJ. The effects of high-flow vs low-flow oxygen on exercise in advanced obstructive airways disease. Chest. 2004;126(4):1108–15. doi: 10.1378/chest.126.4.1108.
    1. Kelly GS, Simon HK, Sturm JJ. High-flow nasal cannula use in children with respiratory distress in the emergency department: predicting the need for subsequent intubation. Pediatr Emerg Care. 2013;29(8):888–92. doi: 10.1097/PEC.0b013e31829e7f2f.
    1. Lenglet H, Sztrymf B, Leroy C, Brun P, Deyfuss D, Ricard J-D. Humidified high flow nasal oxygen during respiratory failure in the emergency department: feasibility and efficacy. Respir Care. 2012;57:1873–8. doi: 10.4187/respcare.01575.
    1. Rello J, Pérez M, Roca O, Poulakou G, Souto J, Laborda C, et al. High-flow nasal therapy in adults with severe acute respiratory infection. A cohort study in patients with 2009 influenza A/H1N1v. J Crit Care. 2012;27:434–9. doi: 10.1016/j.jcrc.2012.04.006.
    1. Messika J, Ahmed KB, Gaudry S, Miguel-Montanes R, Rafat C, Sztrymf B, et al. Use of high-flow nasal cannula oxygen therapy in subjects with ARDS: a 1-year observational study. Respir Care. 2015;60:162–9. doi: 10.4187/respcare.03423.
    1. Poitiers University Hospital. Clinical effect of the association of noninvasive ventilation and high flow nasal oxygen therapy in resuscitation of patients with acute lung injury (FLORALI Study).
    1. Torres A, Gatell JM, Aznar E, El-Ebiary M, Puig de la Bellacasa J, González J, et al. Re-intubation increases the risk of nosocomial pneumonia in patients with needing mechanical ventilation. Am J Respir Crit Care Med. 1995;152(1):137–41. doi: 10.1164/ajrccm.152.1.7599812.
    1. Esteban A, Anzueto A, Frutos F, Alía I, Brochard L, Stewart TE, et al. Characteristics and outcomes in adult patients receiving mechanical ventilation. A 28-day international study. JAMA. 2002;287(3):345–55. doi: 10.1001/jama.287.3.345.
    1. Maggiore SM, Idone FA, Vaschetto R, Festa R, Cataldo A, Antonicelli F, et al. Nasal high-flow versus Venturi mask oxygen therapy after extubation. Am J Respir Crit Care Med. 2014;190:282–8. doi: 10.1164/rccm.201402-0364OC.
    1. Parke R, McGuinness S, Dixon R, Jull A. Open-label, phase II study of routine high-flow nasal oxygen therapy in cardiac surgical patients. Br J Anaesth. 2013;111:925–31. doi: 10.1093/bja/aet262.
    1. Tiruvoipati R, Lewis D, Haji K, Botha J. High-flow nasal oxygen vs high-flow face mask: a randomized crossover trial in extubated patients. J Crit Care. 2010;25(3):463–8. doi: 10.1016/j.jcrc.2009.06.050.
    1. Futier E, Paugam-Burtz C, Constantin J-M, Pereira B, Jaber S. The OPERA trial – comparison of early nasal high flow oxygen therapy with standard care for prevention of postoperative hypoxemia after abdominal surgery: study protocol for a multicenter randomized controlled trial. Trials. 2013;14:341. doi: 10.1186/1745-6215-14-341.
    1. Schwartz DE, Matthay MA, Cohen NH. Death and other complications of emergency airway management in critically ill adults. A prospective investigation of 297 tracheal intubations. Anesthesiology. 1995;82(2):367–76. doi: 10.1097/00000542-199502000-00007.
    1. Mort TC. Emergency tracheal intubation: complications associated with repeated laryngoscopic attempts. Anesth Analg. 2004;99:607–13. doi: 10.1213/01.ANE.0000122825.04923.15.
    1. Baillard C, Fosse JP, Sebbane M. Noninvasive ventilation improves preoxygenation before intubation of hypoxic patients. Am J Respir Crit Care Med. 2006;174:1710177. doi: 10.1164/rccm.200509-1507OC.
    1. Miguel-Montanes R, Hajage D, Messika J, Bertrand F, Gaudry S, Rafat C, et al. Use of high-flow nasal cannula oxygen therapy to prevent desaturation during tracheal intubation of intensive care patients with mild-to-moderate hypoxemia. Crit Care Med. 2015;43:574–83. doi: 10.1097/CCM.0000000000000743.
    1. Cörtük M, Akyol S, Baykan AO, Kiraz K, Uçar H, Cayli M, Kandiş H. Aortic stiffness increases in proportion to the severity of apnea-hypopnea index in patients with obstructive sleep apnea syndrome. Clin Respir J. 2014. doi:10.1111/crj.12244
    1. Sahlin C, Sandberg O, Gustafson Y, Bucht G, Carlberg B, Stenlund H, et al. Obstructive sleep apnea is a risk factor for death in patients with stroke. A 10-year follow-up. Arch Intern Med. 2008;168(3):297–301. doi: 10.1001/archinternmed.2007.70.
    1. Fonseca MI, Pereira T, Caseiro P. Death and disability in patients with sleep apnea – a meta-analysis. Arq Bras Cardiol. 2014;104:58–66.
    1. Marcus CL, Rosen G, Ward S, Halbower AC, Sterni L, Lutz J, et al. Adherence to and effectiveness of positive airway pressure therapy in children with obstructive sleep apnea. Pediatrics. 2006;117:e442. doi: 10.1542/peds.2005-1634.
    1. McGinley BM, Patil SP, Kirkness JP, Smith PL, Schwartz AR, Schneider H. A nasal cannula can be used to treat obstructive sleep apnea. Am J Respir Crit Care Med. 2007;176:194–200. doi: 10.1164/rccm.200609-1336OC.
    1. McGinley B, Halbower A, Schwartz AR, Smith PL, Patil SP, Schneider H. Effect of a high-flow open nasal cannula system on obstructive sleep apnea in children. Pediatrics. 2009;124:179–88. doi: 10.1542/peds.2008-2824.
    1. Haba-Rubio J, Andries D, Rey V, Michel P, Tafti M, Heinzer R. Effect of transnasal insufflation on sleep disordered breathing in acute stroke: a preliminary study. Sleep Breath. 2012;16:759–64. doi: 10.1007/s11325-011-0572-3.
    1. Masip J, Betbesé AJ, Páez J, Vecilla F, Cañizares R, Padró J, et al. Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial. Lancet. 2000;356:2126–32. doi: 10.1016/S0140-6736(00)03492-9.
    1. Carratalá Perales JM, Llorens P, Brouzet B, Albert Jiménez AR, Fernández-Cañadas JM, Carbajosa Dalmau J, et al. High-flow therapy via nasal cannula in acute heart failure. Rev Esp Cardiol. 2011;64:723–5. doi: 10.1016/j.recesp.2010.10.034.
    1. Moriyama K, Satoh T, Motoyasu A, Kohyama T, Kotani M, Kanai R, et al. High-flow nasal cannula therapy in a patient with reperfusion pulmonary edema following percutaneous transluminal pulmonary angioplasty. Case Rep Pulmonol 2014. k0.115/2014/837612.
    1. Lucangelo U, Vassallo FG, Marras E, Ferluga M, Beziza E, Comuzzi L, et al. High-flow nasal interface improves oxygenation in patients undergoing bronchoscopy. Crit Care Res Pract. 2012;2012:506382.
    1. Diab S, Fraser JF. Maintaining oxygenation successfully with high flow nasal cannula during diagnostic bronchoscopy on a postoperative lung transplant patient in the intensive care. Case Rep Crit Care. 2014;2014:198262.
    1. Schettino G, Altobelli N, Kacmarek RM. Noninvasive positive pressure ventilation reverses acute respiratory failure in select “do-not-intubate” patients. Crit Care Med. 2005;33(9):1976–82. doi: 10.1097/01.CCM.0000178176.51024.82.
    1. Levy M, Tanios MA, Nelson D, Short K, Senechia A, Vespia J, et al. Outcomes of patients with do-not-intubate orders treated with noninvasive ventilation. Crit Care Med. 2004;32(10):2002–7. doi: 10.1097/01.CCM.0000142729.07050.C9.
    1. Peters SG, Holets SR, Gay PC. High-flow nasal cannula therapy in do-not-intubate patients with hypoxemic respiratory distress. Respir Care. 2013;58(4):597–600.
    1. Díaz-Lobato S, Folgado MA, Chapa A, Alises SM. Efficacy of high-flow oxygen by nasal cannula with active humidification in a patient with acute respiratory failure of neuromuscular origin. Respir Care. 2013;58(12):e164–7. doi: 10.4187/respcare.02115.
    1. Boyer A, Vargas F, Delacre M, Saint-Léger M, Clouzeau B, Hilbert G, et al. Prognostic impact of high-flow nasal cannula oxygen supply in an ICUY patient with pulmonary fibrosis complicated by acute respiratory failure. Intensive Care Med. 2011;37(3):558–9. doi: 10.1007/s00134-010-2036-9.
    1. Byerly FL, Haithcock JA, Buchanan IB, Short KA, Cairns BA. Use of high flow nasal cannula on a pediatric burn patient with inhalation injury and post-extubation stridor. Burns. 2006;32(1):121–5. doi: 10.1016/j.burns.2005.05.003.
    1. Calvano TP, Sill JM, Kemp KR, Chung KK. Use of high-flow oxygen delivery system in a critically ill patient with dementia. Respir Care. 2008;53(12):1739–43.

Source: PubMed

3
Abonneren